-
1دورية أكاديمية
المؤلفون: Neuville, M F, Paquot, Nicolas, Scheen, André
المصدر: Revue Médicale de Liège, 78 (1), 40-45 (2023-01)
مصطلحات موضوعية: Hypoglycemic Agents, 839I73S42A (Liraglutide), Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptides, Glucagon-Like Peptide 1, Humans, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents/pharmacology/therapeutic use, Liraglutide/pharmacology/therapeutic use, Glucagon-Like Peptide-1 Receptor/agonists, Glucagon-Like Peptides/pharmacology/therapeutic use, Glucagon-Like Peptide 1/therapeutic use, Weight Loss, Obesity/drug therapy, GLP, Glucagon, Obesity, Tirzepatide, Type 2 diabetes, GIP, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition
الوقت: 1
العلاقة: urn:issn:0370-629X; urn:issn:2566-1566; https://orbi.uliege.be/handle/2268/300361Test; info:hdl:2268/300361; https://orbi.uliege.be/bitstream/2268/300361/1/MF-Neuville_2023_78_1.pdfTest; scopus-id:2-s2.0-85146365175; info:pmid:36634066
-
2دورية أكاديمية
المؤلفون: Scheen, André
المصدر: Médecine des Maladies Métaboliques, 17 (5), 399-405 (2023)
مصطلحات موضوعية: Agoniste double GIP/GLP-1, Diabète de type 2, Glucagon, Glucagon-like peptide-1, Glucose-dependent, insulinotropic polypeptide, Insuline, Tirzépatide, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie
العلاقة: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85164697088&doi=10.1016%2fj.mmm.2023.06.006&partnerID=40&md5=f0208c1e7c3faabe00717029506cd276Test; urn:issn:1957-2557; urn:issn:2214-8477; https://orbi.uliege.be/handle/2268/306110Test; info:hdl:2268/306110; scopus-id:2-s2.0-85164697088
-
3دورية أكاديمية
المؤلفون: Scheen, André, Radermecker, Régis, Paquot, Nicolas
المصدر: Revue Médicale Suisse, 18 (792), 1539-1544 (2022-08-24)
مصطلحات موضوعية: Blood Glucose, Glucagon-Like Peptide-1 Receptor, Hypoglycemic Agents, Gastric Inhibitory Polypeptide, Glucagon-Like Peptide 1, OYN3CCI6QE (tirzepatide), Diabetes Mellitus, Type 2/drug therapy/metabolism, Glucagon-Like Peptide-1 Receptor/agonists, Humans, Hypoglycemic Agents/therapeutic use, Human health sciences, Endocrinology, metabolism & nutrition, Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition, Pharmacie, pharmacologie & toxicologie
العلاقة: urn:issn:1660-9379; https://orbi.uliege.be/handle/2268/300352Test; info:hdl:2268/300352; scopus-id:2-s2.0-85136507934; info:pmid:36004653
الإتاحة: https://doi.org/10.53738/REVMED.2022.18.792.1539Test
https://orbi.uliege.be/handle/2268/300352Test